Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction
1 other identifier
interventional
34
1 country
1
Brief Summary
Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2019
CompletedFirst Posted
Study publicly available on registry
February 21, 2019
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2019
CompletedOctober 18, 2019
October 1, 2019
8 months
February 14, 2019
October 16, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Adherence in oral diabetes medications determined by star ratings
Determine change in patients who are adherent to oral diabetes medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.
Baseline to 6 months
Adherence in renin-angiotensin system antagonists (RASA) medications determined by star ratings
Determine change in patients who are adherent to RASA medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.
Baseline to 6 months
Secondary Outcomes (1)
Change in proportion of days covered (PDC)
Baseline to 6 months
Other Outcomes (1)
Satisfaction with education and monitoring service
6 months
Study Arms (1)
Adherence monitoring and education
EXPERIMENTALInterventions
Standardized medication counseling and education combined with individual patient customized guidance and counseling - administered monthly.
Eligibility Criteria
You may qualify if:
- years or older
- Patients pre-identified by Kroger analytics in ClinicalQ - Patients with PDC \< 80%
- Patient taking oral diabetes medications and/or RASA medications (ACE-I, ARB, direct renin inhibitor)
You may not qualify if:
- Patients who are enrolled in MedSync or Autorefill program
- Patients who are lost to follow-up
- Incomplete/missing documentation of an encounter
- Prisoners, children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Venable Goode, PharmD
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2019
First Posted
February 21, 2019
Study Start
March 1, 2019
Primary Completion
October 16, 2019
Study Completion
October 16, 2019
Last Updated
October 18, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share